Not Signed In -
Bupropion SR |
Budeprion SR; Wellbutrin SR |
Clinical Trial: Assessment of Potential Interactions between Methamphetamine and Bupropion - 1
This study is no longer recruiting patients.
Purpose
The purpose of this study is to assess potential interactions between intravenous (IV) methamphetamine and oral bupropion.
| Condition | Treatment or Intervention | Phase |
|---|---|---|
| Amphetamine-Related Disorders | Drug: Bupropion | Phase I |
MedlinePlus related topics: Amphetamine Abuse
Study Type: Interventional
Study Design: Diagnostic, Randomized, Double-Blind, Placebo Control
Official Title: Double-Blind, Placebo-Controlled Assessment of Potential Interactions Between IV Methamphetamine and Oral Bupropion
Expected Total Enrollment: 20
Study start: June 2002; Study completion: September 2003
This is a human laboratory clinical pharmacology study to assess potential interactions between IV methamphetamine challenge and treatment with oral sustained-release bupropion.
Eligibility
Ages Eligible for Study: 18 Years - 45 Years, Genders Eligible for Study: Both
Criteria
Inclusion Criteria:
Please contact site director for more details.
Exclusion Criteria:
Please contact site director for more details.
Location Information
California
UCLA Integrated Substance Abuse Program, Los Angeles, California, 90024, United States
Texas
University of Texas Health Science Center, Houston, Texas, 77225, United States
Thomas Newton, M.D., Principal Investigator, National Institute on Drug Abuse (NIDA)
More Information
Record last reviewed: August 2003
Last Updated: November 18, 2004
Record first received: June 18, 2002
ClinicalTrials.gov Identifier: NCT00040040
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 8, 2005
Resources
- Budeprion SR (Drug Digest)
- Bupropion SR (Drug Digest)
email this page
print this page
bookmark this page
feedback on this page
